Financhill
Back

UroGen Pharma Vs. Lantheus Holdings Industry Stock Comparison

Sell
22

URGN
UroGen Pharma

Last Price:
$10.66
Seasonality Move:
-3.79%
Sell
38

LNTH
Lantheus Holdings

Last Price:
$89.33
Seasonality Move:
14.8%
Sell
22
UroGen Pharma (URGN) is a Sell

Is UroGen Pharma a Buy, Sell or Hold?

  • The current UroGen Pharma [URGN] share price is $10.67. The Score for URGN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Lantheus Holdings (LNTH) is a Sell

Is Lantheus Holdings a Buy, Sell or Hold?

  • The current Lantheus Holdings [LNTH] share price is $89.29. The Score for LNTH is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • LNTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

URGN Stock Price Chart

What is UroGen Pharma's stock price today?

  • The UroGen Pharma share price today is $10.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight selling pressure.

LNTH Stock Price Chart

What is Lantheus Holdings's stock price today?

  • The Lantheus Holdings share price today is $89.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LNTH is experiencing selling pressure, which indicates risk of future bearish movement.

URGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 30.29 Sell
Chaikin Money Flow: -612616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.1 - 12.42) Sell
Bollinger Bands (100): (11.7 - 14.2) Sell

LNTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 44.02 Sell
Chaikin Money Flow: -1065905 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (84.29 - 93.35) Buy
Bollinger Bands (100): (90.29 - 109.87) Sell

URGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.14 Sell
20-day SMA: 11.89 Sell
50-day SMA: 12.03 Sell
200-day SMA: 13.95 Sell
8-day EMA: 11.14 Sell
20-day EMA: 11.58 Sell
50-day EMA: 12.09 Sell
200-day EMA: 13.45 Sell

LNTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.85 Sell
20-day SMA: 90.71 Sell
50-day SMA: 96.46 Sell
200-day SMA: 89.01 Buy
8-day EMA: 91.22 Sell
20-day EMA: 91.13 Sell
50-day EMA: 94.3 Sell
200-day EMA: 90.59 Sell

UroGen Pharma Earnings Growth & URGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

Lantheus Holdings Earnings Growth & LNTH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $0.11 per share.

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lantheus Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):